The association between IGF-I and insulin resistance: A general population study in Danish adults

Diabetes Care

Volumn 35, Issue 4, 2012, Pages 768-773

  Friedrich, Nele ^a   Thuesen, Betina ^b   Jrøgensen, Torben ^b,c   Juul, Anders ^d   Spielhagen, Christin ^a   Wallaschofksi, Henri ^a   Linneberg, Allan ^b  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b Research Centre for Prevention and Health   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOASSAY; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PHYSICAL ACTIVITY; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE; WAIST HIP RATIO;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DENMARK; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; POPULATION; RISK FACTORS; YOUNG ADULT;

EID: 84862064844     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1833     Document Type: Article

References (40)

1. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34
2. Boulware SD, Tamborlane WV, Rennert NJ, Gesundheit N, Sherwin RS. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults. J Clin Invest 1994;93:1131-1139
3. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002;359:1740-1745 (Pubitemid 34607089)
4. Sierra-Johnson J, Romero-Corral A, Somers VK, et al. IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome. Clin Sci (Lond) 2009;116:507-512
5. Schneider HJ, Friedrich N, Klotsche J, et al. Prediction of incident diabetes mellitus by baseline IGF1 levels. Eur J Endocrinol 2011;164:223-229
6. van der Klaauw AA, Biermasz NR, Feskens EJ, et al. The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH. Eur J Endocrinol 2007;156:455-462 (Pubitemid 46672646)
7. Melmed S. Medical progress: acromegaly. N Engl J Med 2006;355:2558-2573
8. Sjögren K, Wallenius K, Liu JL, et al. Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 2001;50:1539-1545 (Pubitemid 33639593)
9. Yakar S, Liu JL, Fernandez AM, et al. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 2001;50:1110-1118 (Pubitemid 32374542)
10. Colao A, Di Somma C, Cascella T, et al. Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Eur J Endocrinol 2008;159:389-397
11. Sesti G, Sciacqua A, Cardellini M, et al. Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care 2005;28:120-125 (Pubitemid 40095793)
12. Thyssen JP, Linneberg A, Menné T, Nielsen NH, Johansen JD. The prevalence andmorbidity of sensitization to fragrance mix I in the general population. Br J Dermatol 2009;161:95-101
13. Saltin B, Grimby G. Physiological analysis of middle-aged and old former athletes. Comparison with still active athletes of the same ages. Circulation 1968;38:1104-1115
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419 (Pubitemid 15018832)
15. Geloneze B, Vasques AC, Stabe CF, et al.; BRAMS Investigators. HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS). Arq Bras Endocrinol Metabol 2009;53:281-287
16. Sørensen K, Aksglaede L, Petersen JH, Leffers H, Juul A. The exon 3 deleted growth hormone receptor gene is associated with small birth size and early pubertal onset in healthy boys. J Clin Endocrinol Metab 2010;95:2819-2826
17. Stone C, Koo CY. Additive splines in statistics. In Proceedings of the Statistical Computing Section ASA. Washington, DC, American Statistical Association, 1985
18. Gatford KL, Egan AR, Clarke IJ, Owens PC. Sexual dimorphism of the somatotrophic axis. J Endocrinol 1998;157:373-389 (Pubitemid 28275837)
19. Ohlsson C, Mohan S, Sjögren K, et al. The role of liver-derived insulin-like growth factor-I. Endocr Rev 2009;30:494-535
20. Span JP, Pieters GF, Sweep FG, Hermus AR, Smals AG. Gender differences in rhGH-induced changes in body composition in GH-deficient adults. J Clin Endocrinol Metab 2001;86:4161-4165 (Pubitemid 32848529)
21. Blaak E. Sex differences in the control of glucose homeostasis. Curr Opin Clin Nutr Metab Care 2008;11:500-504
22. Halldin M, Rosell M, de Faire U, Hellénius ML. The metabolic syndrome: prevalence and association to leisure-time and work-related physical activity in 60-year-old men and women. Nutr Metab Cardiovasc Dis 2007;17:349-357 (Pubitemid 46880264)
23. Møller N, Jørgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 2009;30:152-177
24. Jeffcoate W. Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence. Drug Saf 2002;25:199-212 (Pubitemid 34492939)
25. Attanasio AF, Mo D, Erfurth EM, et al.; International Hypopituitary Control Complications Study Advisory Board. Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement. J Clin Endocrinol Metab 2010;95:74-81
26. Hew FL, Koschmann M, Christopher M, et al. Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. J Clin Endocrinol Metab 1996;81:555-564 (Pubitemid 26055663)
27. Johannsson G, Bengtsson BA. Growth hormone and the metabolic syndrome. J Endocrinol Invest 1999;22(Suppl.):41-46
28. Monson JP, Bengtsson BA, Abs R, Feldt-Rasmussen U, Wüster C. Can growth hormone therapy cause diabetes? KIMS Strategic Committee. Lancet 2000;355:1728-1729 (Pubitemid 30248499)
29. Moller N, Gjedsted J, Gormsen L, Fuglsang J, Djurhuus C. Effects of growth hormone on lipid metabolism in humans. Growth Horm IGF Res 2003;13(Suppl. A):S18-S21 (Pubitemid 37161650)
30. Cousin SP, Hügl SR, Wrede CE, Kajio H, Myers MG Jr, Rhodes CJ. Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinology 2001;142:229-240 (Pubitemid 32183685)
31. Poitout V, Robertson RP. Minireview: Secondary beta-cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002;143:339-342 (Pubitemid 34107184)
32. Wilding JP. The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med 2007;24:934-945 (Pubitemid 47304378)
33. Clemmons DR. Involvement of insulin-like growth factor-I in the control of glucose homeostasis. Curr Opin Pharmacol 2006;6:620-625 (Pubitemid 44752640)
34. Böni-Schnetzler M, Schmid C, Meier PJ, Froesch ER. Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes. Am J Physiol 1991;260:E846-E851
35. Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992;74:1355-1360
36. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994;79:872-878
37. Rasmussen MH, Frystyk J, Andersen T, Breum L, Christiansen JS, Hilsted J. The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. Metabolism 1994;43:315-319 (Pubitemid 24100501)
38. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H. Free insulin-like growth factors in human obesity. Metabolism 1995;44(Suppl. 4):37-44
39. Nam SY, Lee EJ, Kim KR, et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 1997;21:355-359 (Pubitemid 27190186)
40. Rasmussen MH, Hvidberg A, Juul A, et al. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 1995;80:1407-1415